Bringing deals to life.

5-6th February 2018, etc. venues, 200 Aldersgate, St. Pauls, London EC1A 4HD

DOWNLOAD THE PREVIEW BROCHURE
REGISTER NOW

2018 Event Partners

ABOUT THE 2018 WORLD CONGRESS

The 4th annual Biotech and Money / Medtech and Money World Congress is a high-calibre, senior Executive, two-day conference and partnering event providing the education, strategies, solutions and contacts that life science companies need to enable more effective  investment, business planning and partnering within their businesses.

With our relentless focus on quality peer-2-peer discussion, high-level networking and partnering, unique formats and a vetted, high-calibre audience, we bring together the people that matter to the future of healthcare and life science funding, finance, investment and deal making.

The 2017 conference officially attracted the largest gathering of active Life Science investors in Europe, making it the go to event for Executives looking to engage in investment and partnering discussions. It's the must attend 2018 event for corporates, investors and pharma.

DOWNLOAD THE PREVIEW BROCHURE

 

12 EVENTS IN 1 INCREDIBLE 2-DAY CONGRESS

 

              GET THE ADVANCED BROCHURE FOR

  • - The 2017 event stats 
  • - What's new for February 2018
  • - What makes the 2018 event unique
  • - The 2018 agenda and speakers
  • - Who attended in 2017
  • - Plus much more...
DOWNLOAD THE PREVIEW BROCHURE

      2018 KEYNOTES AND SPEAKER FACULTY

 

Tony Hickson
Managing Director, Imperial Innovations

Tim Luker
Director, Eli Lilly

Daniel O'Mahony
Partner, Seroba Life Sciences

Christoph Ruedig
Partner, Albion Ventures

Claudio Rumazza
Partner, Innogest

Alain Huriez
Managing Partner, Advent France Biotechnology

Edoardo Negroni
Managing Partner, AurorA-TT

Gerry Maguire
General Partner, Atlantic Bridge

Giovanni Mariggi
Principal, Medicxi

Edward Van Wezel
Managing Partner, BioGeneration Ventures

James Shaw
Co-Founder, JAG Shaw Baker

Jean-Philippe Combal
CEO, Vivet Therapeutics

Janke Dittmer
Partner, GildeHealthcare

Jennifer Laird
Senior Director, Eli Lilly & Co.

John Zai
CEO, Cocoon Networks

Joachim Rautter
Managing Director, Peppermint

Kate Bingham
Managing Partner, SV Health Investors

Johnston Erwin
Vice President, Eli Lilly & Co.

Jonathan Goldstein
Director, Boston Scientific Ventures

Martin Frost
CEO, Cambridge Medical Robotics

Pascale Auge
CEO, Inserm Transfert

Onno Van De Stolpe
CEO, Galapagos

Piyush Unalkat
Head of Technology Transfer, EIF

Thom Rasche
Partner, Earlybird Venture Capital

Tommi Lehtonen
CEO, Blueprint Genetics

Sander Slootweg
Managing Director, Forbion Capital Partners

Paul Saunders
Head of Innovation Investments, Ireland's Strategic Investment Fund

Paul Ashley
Head of Technology Transfer, Oxford University Innovation

Chandra Leo
Investment Advisor, HBM Partners

Iain Thomas
Head of Life Sciences, Cambridge Enterprise

Rob De Ree
Chairman, Mellon Medical

Steve Atkinson
CEO, Atlantic Therapeutics

 

CURRENT 2018 BIOTECH AND MEDTECH SHOWCASE COMPANIES

 

ENQUIRE ABOUT A SHOWCASE

2018 EVENT VENUE

Address: etc.venues, 200 Aldersgate,

St. Pauls, London, EC1A 4HD

Email: [email protected]

Phone: +44 (0) 20 7105 6090

CONTACT US

Address : Suite 125, The Business Design Centre, 52 Upper St, London N1 0QH, UK

Email: [email protected]

Phone: +44 (0) 203 637 5908